IDEAYA Biosciences, Inc. business relationships

Companies named in IDEAYA Biosciences, Inc.’s 10-K filed 2026-02-17, and public companies whose annual reports name IDEAYA Biosciences, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 5.4 / 10
AI naming: 70 / 100
Agent readiness: 0 / 100
AI adoption: 0 / 100

Named in IDEAYA Biosciences, Inc.’s annual report 10

NOVARTIS AG (NVS)Licensee7.7
“We control the prosecution and maintenance of the patents exclusively licensed to us, with Novartis retaining step-in rights if we do not continue such prosecution and maintenance.” SEC filing
NOVARTIS AG (NVS)Licensor7.7
“Under the license agreement, Novartis granted to us a worldwide, exclusive, sublicensable license to research, develop, manufacture, and commercialize certain defined compounds and products, including IDE196 and certain other PKC inhibitors, as well as companion diagnostic products, collectively ref...” SEC filing
PFIZER INC (PFE)Licensor7.7
“(1) Pursuant to Pfizer License Agreements” SEC filing
GILEAD SCIENCES, INC. (GILD)Partner7.7
“On February 12, 2025, we entered into the Second Gilead CSCSA with Gilead pursuant to which we and Gilead will collaborate on a portion of our Phase 1 study for the clinical evaluation of IDE397 in combination with Trodelvy (the Combination Study), in certain patients with advanced solid tumors in l...” SEC filing
PFIZER INC (PFE)Partner7.7
“We are collaborating with Pfizer and Gilead on the clinical development of darovasertib in UM and IDE397 for MTAP-deleted UC and NSCLC, respectively.” SEC filing
GILEAD SCIENCES, INC. (GILD)Supplier7.7
“Clinical Study Collaboration and Supply Agreement with Gilead for IDE397” SEC filing
PFIZER INC (PFE)Supplier7.7
“Clinical Trial Collaboration and Supply Agreements with Pfizer for Darovasertib” SEC filing
GSK plc (GSK)Licensor5.5
“Collaboration, Option and License Agreement with GSK for Pol Theta and Werner Helicase” SEC filing
GSK plc (GSK)Partner5.5
“We and GSK collaborated on preclinical research for the Pol Theta and WRN programs.” SEC filing
Jiangsu Hengrui Pharmaceuticals Co (JHPCY)Licensor-
“Pharmaceuticals (Beijing) Co. Ltd. (Biocytogen), our License Agreement with Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma), and our License Agreement with Les Laboratoires Servier (Servier);” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.